On this page
Congenital melanocytic naevus (giant)
This condition involves areas of discoloured skin, known as naevi (moles), which are significantly larger than typical moles. It arises from changes affecting skin cell growth during development and can have various clinical implications.
Available at Jeen Health
Clinical tests that include this
Overview
Congenital melanocytic naevus (CMN) refers to a type of mole or birthmark that is present at birth. When these naevi are particularly large, they are often described as 'giant CMN'. These lesions typically appear as brown or black patches on the skin, sometimes with a textured or hairy surface [PMID:33604085]. Giant CMN is a rare condition, affecting approximately 1 in 20,000 newborns.
The size of a giant CMN is an important factor. While there isn't one universal definition, they are generally considered giant if they will reach an adult diameter of more than 20 cm, or cover more than a certain percentage of the body surface. The presence and size of these naevi can influence clinical considerations and management approaches.
Symptoms & clinical features
The primary symptom of giant CMN is the visible naevus itself. These birthmarks can vary significantly in appearance; they may be flat or raised, smooth or bumpy, and can range in colour from light brown to black. Hair growth within the naevus is also common. The size of the naevus is a key characteristic, often covering a substantial area of the body such as a limb, the torso, or the scalp.
Over time, some changes can occur within the naevus, including alterations in colour, texture, or the development of new bumps or nodules. Individuals with giant CMN may also develop numerous smaller moles, known as satellite naevi, elsewhere on their body [PMID:24750174]. While most changes within a giant CMN are benign, careful monitoring is usually recommended.
Video: Genetics 101
Affected organs
Giant congenital melanocytic naevi primarily affect the skin. The pigmented cells (melanocytes) that form the naevus are located in the skin layers. In some cases, particularly with large or extensive naevi, the cells that form the naevus can also be found in other tissues, most commonly the central nervous system (brain and spinal cord). This is known as neurocutaneous melanosis.
Neurocutaneous melanosis can lead to various neurological symptoms if the cells affect critical areas or cause fluid build-up [PMID:24750174]. These symptoms might include seizures, developmental delay, or problems with brain fluid circulation (hydrocephalus). Not all individuals with giant CMN will develop neurocutaneous melanosis, but screening may be considered, especially if symptoms suggest involvement beyond the skin.
Risks & severity
The severity of giant CMN is often related to its size and location, as well as the potential for complications. One of the main concerns is a slightly increased lifetime risk of developing melanoma, a type of skin cancer, within the naevus [PMID:33604085]. This risk is generally higher for larger naevi. The age at which this might occur can vary, with some cases reported in childhood, though it is more common in adulthood.
Another potential risk associated with giant CMN, particularly those covering the head or back, is neurocutaneous melanosis, . This condition can lead to neurological problems, and its severity depends on the extent of brain or spinal cord involvement. The overall impact of giant CMN can also include psychological and social challenges due to the visible nature of the birthmark.
Genetic causes
Giant congenital melanocytic naevus is primarily caused by changes (mutations) in the NRAS gene. The NRAS gene provides instructions for making the N-Ras protein, which plays a critical role in cell growth, division, and specialisation. This protein acts like a molecular switch, helping cells respond to signals from their environment.
In giant CMN, a specific type of genetic change, called a somatic mutation, occurs in NRAS. 'Somatic' means this change happens in individual cells early during development after conception, rather than being inherited from a parent. These changes lead to the N-Ras protein being constantly 'switched on', promoting uncontrolled growth of melanocytes, resulting in the formation of the large naevus. Because these changes occur early in development, they are typically mosaic, meaning that only some cells in the body carry the mutation, specifically those within the naevus itself [PMID:24750174].
- NRAS NRAS proto-oncogene, GTPaseThe NRAS gene provides instructions for a protein called N-Ras, central to regulating cell division, differentiation, and relaying signals within cells.
Inheritance pattern
Giant congenital melanocytic naevus follows a somatic or mosaic inheritance pattern. This means the genetic change causing the condition occurs spontaneously in a single cell very early in the development of the foetus, and is not inherited from either parent. The changed gene is then passed on to all the daughter cells derived from that initial abnormal cell, resulting in a 'patch' of affected tissue - the naevus.
As the genetic change is somatic and not present in the germline (sperm or egg cells), it is generally not passed on to children. Therefore, the risk of future children having giant CMN is typically considered to be very low, similar to the general population risk. Family members are not usually affected, as it is not an inherited condition in the traditional sense.
Diagnosis & testing
Diagnosing giant congenital melanocytic naevus usually involves a clinical examination by a paediatrician or dermatologist at birth or shortly thereafter. The characteristic appearance and large size of the pigmented lesion are key indicators. Imaging studies, such as MRI, may be considered to screen for neurocutaneous melanosis, especially if the naevus is in a high-risk location (e.g., covering the scalp or extensive areas of the back) or if neurological symptoms are present [PMID:33604085].
Genetic testing for the NRAS gene mutation can confirm the diagnosis, particularly in ambiguous cases or for research purposes. This testing is typically performed on a biopsy sample from the naevus tissue itself. Individuals suspected of having giant CMN can be referred to Clinical Genetics services or specialist dermatology clinics within the NHS for full evaluation and ongoing care. Genetic testing for this condition would fall under relevant NHS Genomic Medicine Service (GMS) pathways, often initiated via an R-code within the GMS (e.g., R51 for Naevus or R93 for General skin disorders).
Management & lifestyle
Management of giant CMN focuses on monitoring for changes within the naevus, addressing cosmetic concerns, and managing potential complications. Regular skin examinations by a dermatologist are typically recommended to look for suspicious changes that might suggest melanoma. Education on self-monitoring for warning signs is also important.
Due to the visible nature of the naevus, surgical removal may be considered for some individuals. This can be complex, often requiring multiple stages, and the decision depends on the size, location, and potential risks of the naevus, as well as the wishes of the individual and their family. Psychological support is also a valuable part of care for those affected and their families. If neurocutaneous melanosis is present, management will involve a multidisciplinary team, potentially including neurologists, to address any neurological symptoms.
UK care pathway
In the UK, individuals with a suspected diagnosis of giant congenital melanocytic naevus are typically referred to specialist paediatric dermatology services for assessment and ongoing management. Genetic testing, if deemed appropriate by a clinician, is available through the NHS Genomic Medicine Service (GMS) under specific R-codes, such as R51 for Naevus or R93 for General skin disorders. A referral to Clinical Genetics is usually made by the treating specialist, such as a paediatrician or dermatologist. Genetic counsellors play a vital role in explaining the condition, inheritance patterns, and the implications of genetic test results to families.
Frequently asked questions
Will my other children be affected by giant congenital melanocytic naevus?
No, giant congenital melanocytic naevus is typically not inherited. It results from a spontaneous genetic change that occurs very early in development, meaning it is generally not passed down to future children. The risk for your other children is usually not increased above that of the general population.
What is the likelihood of the naevus becoming cancerous?
Individuals with giant CMN have a slightly increased lifetime risk of developing melanoma within the naevus compared to the general population. Regular monitoring by a dermatologist is important to detect any concerning changes early.
Is surgical removal always necessary for a giant CMN?
Surgical removal is a complex decision and is not always necessary. It depends on various factors, including the size and location of the naevus, potential risks, and if there are significant cosmetic concerns. Your dermatologist will discuss the best options for your specific situation.
What is neurocutaneous melanosis?
Neurocutaneous melanosis is a rare condition where the same type of cell that forms the naevus is also found in the brain and spinal cord. It is a potential complication of giant CMN, particularly with very large or extensive naevi. It can sometimes lead to neurological symptoms.
How often does the naevus need to be checked by a doctor?
Regular check-ups with a dermatologist are typically recommended. The frequency will depend on the size and characteristics of the naevus, as well as individual circumstances. Your dermatologist will advise on the appropriate schedule.